Tool for Evaluating RWE in the Treatment of Retinal Disease Randomized clinical trials have long been held as the gold standard for evidence based medical practices. However, there is a growing consciousness about the value of incorporating data from real world based evidence into clinical decision making. Information from real world sources such
Ophthalmology
The Future of Glaucoma Therapy? Microneedles and the Reduction of Intraocular Pressure
The Future of Glaucoma Therapy? Microneedles and the Reduction of Intraocular Pressure Around 75 million people suffer from glaucoma, making it the world’s leading eye disorder that causes irreversible blindness. Vision loss in glaucoma patients is often accompanied by the dysfunction of the retinal ganglion cell axons. This is believed to
Diagnosis And Management of Nocardia Keratitis
Diagnosis And Management of Nocardia Keratitis Keratitis refers to infection of the cornea, the dome covering the eye’s iris and pupil. Keratitis may or may not be caused by an infection. Minor injury to the eye, extended-wear contact lenses, or foreign bodies are the most common causatives of non-infectious keratitis. Infectious
Retinal Nerve Fiber Layer Thickness In Alzheimer’s Disease
Retinal Nerve Fiber Layer Thickness In Alzheimer’s Disease Worldwide, nearly 50 million people live with Alzheimer’s or related dementia according to Alzheimer's Disease International (ADI). If breakthroughs are not discovered, this population could triple to 152 million by the year 2050. Alzheimer’s disease (AD) accounts for around two-thirds of all dementia
Analysis of The Study on Adverse Reactions to 1% Cyclopentolate Eye Drop in Children
Analysis of The Study on Adverse Reactions to 1% Cyclopentolate Eye Drop in Children Cyclopentolate hydrochloride is a drug used before routine eye examinations such as refraction exams. It is often characterized by a faster onset and shorter duration of action compared to its alternative cycloplegic eye drop atropine sulfate hydrate. Refractive
Study results: Use of atropine to control progression of myopia
STUDY RESULTS: USE OF ATROPINE TO CONTROL PROGRESSION OF MYOPIA Myopia is one of the most common eye diseases in the world. It has also become the leading cause of blindness. In a study of 2.1 million participants, results suggest that approximately 2.7% of the world population has myopia. The rate of
Study results: Underutilization of generics by U.S. Ophthalmologists
One of the highest healthcare costs for patients in the United States is prescription drug spending. Each year prescription drug spending reaches around $300 billion of the total national healthcare expenditure, this number keeps on rising every year. Generic medications are approved by the FDA and have similar effectiveness and
Study Results: ophthalmologic problems amongst patients with Parkinson’s disease
Parkinson’s disease is a movement disorder that affects around 10 million people around the world. It is characterized as a chronic and neurodegenerative disorder that leads to tremors, slowness of movement, impaired balance, and other non-motor symptoms such as sexual dysfunction, loss of senses, and gastrointestinal issues. But perhaps one
